Come up with a name for your new list and we'll add to it:
Domain Therapeutics raised a round of funding on April 14, 2014. Investors include
The Michael J. Fox Foundation.
Domain Therapeutics, formerly Faust Pharmaceuticals, is a biopharmaceutical company dedicated to the discovery and early development of small molecules targeting G-Protein Coupled Receptors (GPCRs). D…